title: [Use of chemotherapy and radiotherapy in the treatment of urothelial carcinoma of the upper urinary tract].
abstract: Urothelial carcinomas of the upper urinary tract are rare entities. Surgery remains the mainstay of the management. The use of others therapeutic modalities is not clearly defined yet. However, the frequency of local recurrence and locoregional encourage us to evaluate the indication of adjuvant therapies. We conducted a synthesis of key data in the literature on the use of chemotherapy and radiotherapy in the treatment of urothelial carcinoma of the renal pelvis and ureter. A literature search on PubMed was performed using the following keywords (MeSH) "urothelial carcinoma", "upper urinary tract", "radiation", "chemotherapy", and adjuvant.
authors.affiliation: Département de radiothérapie, institut de cancérologie de l'Ouest, site Paul-Papin, 2, rue Moll, 49000 Angers, France. Electronic address: pit_gustin@hotmail.com.
authors.forename: P
authors.initials: P
authors.lastname: Gustin
authors.affiliation: Département de radiothérapie, institut de cancérologie de l'Ouest, site Paul-Papin, 2, rue Moll, 49000 Angers, France.
authors.forename: S
authors.initials: S
authors.lastname: Yossi
authors.affiliation: Département de radiothérapie, institut de cancérologie de l'Ouest, site Paul-Papin, 2, rue Moll, 49000 Angers, France.
authors.forename: M
authors.initials: M
authors.lastname: Lafont
authors.affiliation: Département de radiothérapie, institut de cancérologie de l'Ouest, site Paul-Papin, 2, rue Moll, 49000 Angers, France.
authors.forename: G
authors.initials: G
authors.lastname: Peyraga
authors.affiliation: Département de radiothérapie, institut de cancérologie de l'Ouest, site Paul-Papin, 2, rue Moll, 49000 Angers, France.
authors.forename: P
authors.initials: P
authors.lastname: Trémolières
authors.affiliation: Département de radiothérapie, institut de cancérologie de l'Ouest, site Paul-Papin, 2, rue Moll, 49000 Angers, France.
authors.forename: D
authors.initials: D
authors.lastname: Rousseau
authors.affiliation: Département de radiothérapie, institut de cancérologie de l'Ouest, site Paul-Papin, 2, rue Moll, 49000 Angers, France.
authors.forename: P
authors.initials: P
authors.lastname: Cellier
authors.affiliation: Département de radiothérapie, institut de cancérologie de l'Ouest, site Paul-Papin, 2, rue Moll, 49000 Angers, France.
authors.forename: A
authors.initials: A
authors.lastname: Paumier
authors.affiliation: Service d'urologie, CHU d'Angers, 4, rue Larrey, 49933 Angers cedex 9, France.
authors.forename: F
authors.initials: F
authors.lastname: Martin
authors.affiliation: Département de radiothérapie, centre hospitalier Lyon-Sud, hospices civils de Lyon, 165, chemin du Grand-Revoyet, 69495 Pierre-Bénite, France.
authors.forename: O
authors.initials: O
authors.lastname: Chapet
authors.affiliation: Département de radiothérapie, institut de cancérologie de l'Ouest, site Paul-Papin, 2, rue Moll, 49000 Angers, France.
authors.forename: N
authors.initials: N
authors.lastname: Mesgouez-Nebout
mesh_terms: D002295:Carcinoma, Transitional Cell / Q000628:therapy*; D017024:Chemotherapy, Adjuvant; D003131:Combined Modality Therapy; D005260:Female; D006801:Humans; D007680:Kidney Neoplasms / Q000473:pathology / Q000628:therapy*; D008297:Male; D009364:Neoplasm Recurrence, Local / Q000517:prevention & control; D009367:Neoplasm Staging; D009392:Nephrectomy; D058958:Organs at Risk; D011832:Radiation Injuries / Q000517:prevention & control; D011879:Radiotherapy Dosage; D018714:Radiotherapy, Adjuvant; D020266:Radiotherapy, Conformal; D015996:Survival Rate; D014513:Ureter / Q000601:surgery; D014516:Ureteral Neoplasms / Q000473:pathology / Q000628:therapy*
keywords: Adjuvant treatment; Carcinome urothélial; Chemotherapy; Chimiothérapie; Radiotherapy; Radiothérapie; Traitement adjuvant; Upper urinary tract; Urothelial carcinoma; Voie excrétrice urinaire supérieure